Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees

May 9, 2018 updated by: Katie McClendon, University of Mississippi Medical Center

Objective: to assess the health and economic outcomes (weight lost, change in control of chronic diseases such as diabetes, quality of life, work productivity, health care cost, etc) associated with bariatric (weight-loss) surgery for 200 severely obese patients who undergo bariatric surgery as part of the Mississippi State Employees' Life and Health Insurance Plan's Obesity Treatment Program (OTP).

2. Patient Characteristics: Inclusion criteria: Eligible bariatric surgical candidates who are enrolled in the OTP (100 patients per year for 2 years). The Plan's criteria includes, but is not limited to 1) enrollment in the plan for at least 12 consecutive months prior to September 1, 2009; 2) completion of the HealthQuotient health risk assessment through the Plan's wellness and health promotion program; 3) a Body Mass Index (BMI) of >40 kg/m2, or a BMI >35 kg/m2 with two or more co-morbidities such as diabetes, hypertension, sleep apnea or asthma; 4) two or more physician-supervised weight loss attempts within the last 24 months; 5) age 18 years or older; and 6) consent to provide personal and medical information to the Plan. Prior to surgery, each site administers a psychiatric evaluation to ensure the patient is psychologically stable for surgery. Exclusion criteria: any patient who does not meet criteria above or who declines to participate. Surgeries will take place only at Certified Bariatric Surgery Centers of Excellence (COE), of which, there are currently 3 in the state. The 3 COEs exist with 4 outpatient medical offices (1 COE is composed of 2 independent surgeon practices) Patients will be recruited at each site once they are approved by the OTP.

3. Design: prospective, observational, multi-center, longitudinal study of outcomes and resource utilization associated with OTP. Estimates of obesity and comorbidities' impact will be obtained from the outpatient medical office for the COEs. Medical charts, databases and medical/pharmacy claims will be the source of information. Surveys on quality of life, productivity, and patient satisfaction will be administered directly to patients. Database claim information will be obtained in future and is not a part of current IRB application.

4: Procedures: After obtaining informed consent, patients will be administered surveys at baseline, as well as at follow-up visits. Additional data will be obtained via patient charts, databases, and medical/pharmacy claims.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

165

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Mississippi
      • Jackson, Mississippi, United States, 39204
        • Central Mississippi Medical Center Comprehensive Weight Management Program
      • Oxford, Mississippi, United States, 28677
        • Oxford Bariatric
      • Oxford, Mississippi, United States, 38677
        • Oxford Surgical & Bariatric Clinic,LLC.
      • Pascagoula, Mississippi, United States, 39567
        • South Mississippi Surgical Weight Loss Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

200 obese patients with Mississippi State Employee Insurance who undergo bariatric surgery as part of Obesity Treatment Program

Description

Inclusion Criteria:

  • Eligible bariatric surgical candidates who are enrolled in the Mississippi SSELHI Plan (100 candidates enrolled per year). The Plan's criteria includes, but is not limited to

    1. enrollment in the plan for at least 12 consecutive months prior to September 1, 2009
    2. completion of the HealthQuotient health risk assessment through the Plan's wellness and health promotion program
    3. a Body Mass Index (BMI) of >40 kg/m2, or a BMI >35 kg/m2 with two or more co-morbidities such as diabetes, hypertension, sleep apnea or asthma
    4. two or more physician-supervised weight loss attempts within the last 24 months
    5. consent to provide personal and medical information to the Plan

Exclusion Criteria:

  • Any patient who does not meet criteria above or who declines to participate.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight loss
Time Frame: 0, 6, 12, and 24 months
change in weight from baseline
0, 6, 12, and 24 months
Body mass index (BMI)
Time Frame: 0, 6, 12, and 24 months
Change in body mass index (BMI) from baseline
0, 6, 12, and 24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ecomonic outcomes
Time Frame: 0, 6, 12, and 24 months
costs to the insurance plan were assessed
0, 6, 12, and 24 months
Systolic blood pressure
Time Frame: 0, 6, 12, and 24 months
change in systolic blood pressure from baseline
0, 6, 12, and 24 months
Diastolic blood pressure
Time Frame: 0, 6, 12, and 24 months
change in diastolic blood pressure from baseline
0, 6, 12, and 24 months
Medication use
Time Frame: 0, 6, 12, and 24 months
Change in mean number of medications prescribed
0, 6, 12, and 24 months
quality of life
Time Frame: 0, 6, 12, and 24 months
Impact of weight on quality of life (IWQOL-lite) questionnaire; tool assesses 5 domains of quality of life: physical function, self-esteem, sexual life, public distress, and work impact
0, 6, 12, and 24 months
Work productivity
Time Frame: 0, 6, 12, and 24 months
Work productivity and activity impairment questionnaire: General Health v2.0 (WPAI:GH) assesses work productivity
0, 6, 12, and 24 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Surgery-related adverse events
Time Frame: 24 months
Any surgery-related adverse events were noted
24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Katie S McClendon, Pharm.D., University of Mississippi Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2010

Primary Completion (Actual)

June 1, 2014

Study Completion (Actual)

June 1, 2014

Study Registration Dates

First Submitted

July 13, 2010

First Submitted That Met QC Criteria

July 13, 2010

First Posted (Estimate)

July 14, 2010

Study Record Updates

Last Update Posted (Actual)

May 15, 2018

Last Update Submitted That Met QC Criteria

May 9, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 41165

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

3
Subscribe